Entry |
|
Name |
Selumetinib (USAN/INN) |
Formula |
C17H15BrClFN4O3
|
Exact mass |
456.0000
|
Mol weight |
457.68
|
Structure |
|
Simcomp |
|
Class |
|
Remark |
Product (DG01414): | D10024<JP/US> |
|
Efficacy |
Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor |
Target |
|
Pathway |
|
Metabolism |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EE04 Selumetinib
D09666 Selumetinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01414 Selumetinib
D09666 Selumetinib
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG01642 CYP2C9 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG01639 CYP2C19 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG02855 CYP2E1 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG02925 CYP3A5 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG01414 Selumetinib
D09666 Selumetinib
DG03184 UGT1A3 substrate
DG01414 Selumetinib
D09666 Selumetinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
STE group
MAP2K1 (MEK1)
D09666 Selumetinib (USAN/INN)
MAP2K2 (MEK2)
D09666 Selumetinib (USAN/INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09666
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01414 Selumetinib
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG01414 Selumetinib
DG01642 CYP2C9 substrate
DG01414 Selumetinib
DG01639 CYP2C19 substrate
DG01414 Selumetinib
DG02855 CYP2E1 substrate
DG01414 Selumetinib
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01414 Selumetinib
DG02925 CYP3A5 substrate
DG01414 Selumetinib
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG01414 Selumetinib
DG03184 UGT1A3 substrate
DG01414 Selumetinib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C8y C 27.5800 -23.9400
2 C8y C 27.5800 -25.3400
3 C8x C 26.3900 -26.0400
4 C8y C 25.1300 -25.3400
5 C8y C 25.1300 -23.9400
6 C8y C 26.3900 -23.2400
7 N5x N 28.9100 -23.5200
8 C8x C 29.7500 -24.6400
9 N4y N 28.9100 -25.8300
10 X F 26.3900 -21.8400
11 N1b N 23.9400 -23.2400
12 C5a C 23.9400 -26.1100
13 N1b N 22.6800 -25.4100
14 O5a O 23.9400 -27.5100
15 O2a O 21.5600 -26.0400
16 C1b C 20.3000 -25.4100
17 C8y C 23.9400 -21.8400
18 C8y C 22.7500 -21.1400
19 C8x C 22.7500 -19.7400
20 C8y C 23.9400 -19.0400
21 C8x C 25.1300 -19.7400
22 C8x C 25.1300 -21.1400
23 X Br 23.9400 -17.6400
24 X Cl 21.4900 -21.8400
25 C1a C 29.3300 -27.1600
26 C1b C 19.1100 -26.0400
27 O1a O 17.9200 -25.4100
BOND 29
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 2
9 8 9 1
10 2 9 1
11 6 10 1
12 5 11 1
13 4 12 1
14 12 13 1
15 12 14 2
16 13 15 1
17 15 16 1
18 11 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 20 23 1
26 18 24 1
27 9 25 1
28 16 26 1
29 26 27 1
|